Trial intelligence / Profile preview

Propofol-based total intravenous anesthesia versus inhalational anesthesia in colorectal cancer surgery

PACTR202102898053019Recruiting

Sponsor
Mansoura University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol in colorectal cancer (CRC) (2 arms), sponsored by Mansoura University. Primary endpoint: 1-year cancer-free survival. Started Mar 2021; status: recruiting.

02

Drugs

propofol
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on PACTR202102898053019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202102898053019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call